Your browser doesn't support javascript.
loading
Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids.
Middelkoop, Mei-An; de Lange, Maria E; Clark, T Justin; Mol, Ben Willem J; Bet, Pierre M; Huirne, Judith A F; Hehenkamp, Wouter J K.
Afiliação
  • Middelkoop MA; Department of Obstetrics and Gynaecology, Amsterdam Reproduction and Development, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • de Lange ME; Department of Obstetrics and Gynaecology, Amsterdam Reproduction and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Clark TJ; Department of Obstetrics and Gynaecology, Birmingham Women's and Children's Hospital, Birmingham, UK.
  • Mol BWJ; Department of Obstetrics and Gynaecology, Monash University Monash Medical Centre, Clayton, Victoria, Australia.
  • Bet PM; Department of Obstetrics and Gynaecology, Aberdeen Centre for Women's Health Research, University of Aberdeen, Aberdeen, UK.
  • Huirne JAF; Department of Obstetrics and Gynaecology, University of Aberdeen Aberdeen, Aberdeen, UK.
  • Hehenkamp WJK; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Hum Reprod ; 37(5): 884-894, 2022 05 03.
Article em En | MEDLINE | ID: mdl-35143669

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Leiomioma / Norpregnadienos Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Hum Reprod Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Leiomioma / Norpregnadienos Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Hum Reprod Ano de publicação: 2022 Tipo de documento: Article